BASF increases prices for vitamin B2
BASF globally increases the price for vitamin B2 products for human and animal nutrition by
10% as of May 10, 2010, respectively in line with existing commitments.
Furthermore, BASF is to shut down the production of vitamin B2 at its facility in Gunsan, South Korea, during August 2010 a few weeks to conduct its annual routine overhaul. BASF will continue to meet all supply commitments to customers during that time.
This price increase is necessary to reflect higher prices for raw materials.
BASF produces vitamin B2 (riboflavin) by fermentation.
Chinese price rise
Also the world's largest vitamin B2 active pharmaceutical ingredient (API) manufacturer, Hubei Guangji Pharmaceutical Co. Ltd., announced on May 12 that it has raised the price of its vitamin B2 API used for animal feed.
To comment, register here
Or register to be able to comment.